Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Neuropharmacology. 2021 Oct 4;200:108820. doi: 10.1016/j.neuropharm.2021.108820

Table 2.

Potency of MDPV and analogs inhibiting DA-induced Ca2+ signals at the indicated transporters.

Construct, pIC50 ± SEM (M), (IC50 nM; # cells analyzed)
wt dDAT triple dDAT mut quad dDAT mut wt hDAT
MDPV 4.56 ± 0.02 (27,350; 437) 5.92 ± 0.02 (1,207; 438) 6.60 ± 0.04 (251; 396) 7.47 ± 0.01 (34; 459)
α-PVP 4.68 ± 0.03 (20,710; 699) 5.82 ± 0.03 (1,531; 599) 5.96 ± 0.03 (1,094; 481) 7.29 ± 0.01 (51; 569)
MDPPP Inactive (>>30,000; 246) 4.80 ± 0.02 (15,960; 551) 4.89 ± 0.01 (12,950; 507) 5.47 ± 0.02 (3,418; 639)